Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gleevec
1.2.3 Sprycel
1.2.4 Tasigna
1.2.5 Clolar
1.2.6 Others
1.3 Market by Application
1.3.1 Global Leukemia Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Therapeutics Market Perspective (2018-2033)
2.2 Leukemia Therapeutics Growth Trends by Region
2.2.1 Global Leukemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Leukemia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Leukemia Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Leukemia Therapeutics Market Dynamics
2.3.1 Leukemia Therapeutics Industry Trends
2.3.2 Leukemia Therapeutics Market Drivers
2.3.3 Leukemia Therapeutics Market Challenges
2.3.4 Leukemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Therapeutics Players by Revenue
3.1.1 Global Top Leukemia Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Leukemia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leukemia Therapeutics Revenue
3.4 Global Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutics Revenue in 2022
3.5 Leukemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Leukemia Therapeutics Product Solution and Service
3.7 Date of Enter into Leukemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Therapeutics Breakdown Data by Type
4.1 Global Leukemia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Leukemia Therapeutics Forecasted Market Size by Type (2024-2033)
5 Leukemia Therapeutics Breakdown Data by Application
5.1 Global Leukemia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Leukemia Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Leukemia Therapeutics Market Size (2018-2033)
6.2 North America Leukemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Leukemia Therapeutics Market Size by Country (2018-2023)
6.4 North America Leukemia Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Therapeutics Market Size (2018-2033)
7.2 Europe Leukemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Leukemia Therapeutics Market Size by Country (2018-2023)
7.4 Europe Leukemia Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Leukemia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Leukemia Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Leukemia Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukemia Therapeutics Market Size (2018-2033)
9.2 Latin America Leukemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Leukemia Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Leukemia Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Leukemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Leukemia Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Leukemia Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Leukemia Therapeutics Introduction
11.1.4 Roche Revenue in Leukemia Therapeutics Business (2018-2023)
11.1.5 Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Leukemia Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Leukemia Therapeutics Introduction
11.3.4 Novartis Revenue in Leukemia Therapeutics Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Leukemia Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Leukemia Therapeutics Introduction
11.5.4 Eisai Revenue in Leukemia Therapeutics Business (2018-2023)
11.5.5 Eisai Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Detail
11.6.2 Biogen Idec Business Overview
11.6.3 Biogen Idec Leukemia Therapeutics Introduction
11.6.4 Biogen Idec Revenue in Leukemia Therapeutics Business (2018-2023)
11.6.5 Biogen Idec Recent Development
11.7 ERYtech Pharma
11.7.1 ERYtech Pharma Company Detail
11.7.2 ERYtech Pharma Business Overview
11.7.3 ERYtech Pharma Leukemia Therapeutics Introduction
11.7.4 ERYtech Pharma Revenue in Leukemia Therapeutics Business (2018-2023)
11.7.5 ERYtech Pharma Recent Development
11.8 Celgene
11.8.1 Celgene Company Detail
11.8.2 Celgene Business Overview
11.8.3 Celgene Leukemia Therapeutics Introduction
11.8.4 Celgene Revenue in Leukemia Therapeutics Business (2018-2023)
11.8.5 Celgene Recent Development
11.9 Genmab
11.9.1 Genmab Company Detail
11.9.2 Genmab Business Overview
11.9.3 Genmab Leukemia Therapeutics Introduction
11.9.4 Genmab Revenue in Leukemia Therapeutics Business (2018-2023)
11.9.5 Genmab Recent Development
11.10 Cephalon
11.10.1 Cephalon Company Detail
11.10.2 Cephalon Business Overview
11.10.3 Cephalon Leukemia Therapeutics Introduction
11.10.4 Cephalon Revenue in Leukemia Therapeutics Business (2018-2023)
11.10.5 Cephalon Recent Development
11.11 Clavis Pharma
11.11.1 Clavis Pharma Company Detail
11.11.2 Clavis Pharma Business Overview
11.11.3 Clavis Pharma Leukemia Therapeutics Introduction
11.11.4 Clavis Pharma Revenue in Leukemia Therapeutics Business (2018-2023)
11.11.5 Clavis Pharma Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Leukemia Therapeutics Introduction
11.12.4 Pfizer Revenue in Leukemia Therapeutics Business (2018-2023)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gleevec
Table 3. Key Players of Sprycel
Table 4. Key Players of Tasigna
Table 5. Key Players of Clolar
Table 6. Key Players of Others
Table 7. Global Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Leukemia Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Leukemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Leukemia Therapeutics Market Share by Region (2018-2023)
Table 11. Global Leukemia Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Leukemia Therapeutics Market Share by Region (2024-2033)
Table 13. Leukemia Therapeutics Market Trends
Table 14. Leukemia Therapeutics Market Drivers
Table 15. Leukemia Therapeutics Market Challenges
Table 16. Leukemia Therapeutics Market Restraints
Table 17. Global Leukemia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Leukemia Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutics as of 2022)
Table 20. Ranking of Global Top Leukemia Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Leukemia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Leukemia Therapeutics Product Solution and Service
Table 24. Date of Enter into Leukemia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Leukemia Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Leukemia Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Leukemia Therapeutics Revenue Market Share by Type (2024-2033)
Table 30. Global Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Leukemia Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Leukemia Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Leukemia Therapeutics Revenue Market Share by Application (2024-2033)
Table 34. North America Leukemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Leukemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Leukemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Leukemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Leukemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Leukemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Leukemia Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Leukemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Leukemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Leukemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Leukemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Leukemia Therapeutics Product
Table 52. Roche Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. GlaxoSmithKline Company Detail
Table 55. GlaxoSmithKline Business Overview
Table 56. GlaxoSmithKline Leukemia Therapeutics Product
Table 57. GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 58. GlaxoSmithKline Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Leukemia Therapeutics Product
Table 62. Novartis Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Leukemia Therapeutics Product
Table 67. Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Eisai Company Detail
Table 70. Eisai Business Overview
Table 71. Eisai Leukemia Therapeutics Product
Table 72. Eisai Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Eisai Recent Development
Table 74. Biogen Idec Company Detail
Table 75. Biogen Idec Business Overview
Table 76. Biogen Idec Leukemia Therapeutics Product
Table 77. Biogen Idec Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Biogen Idec Recent Development
Table 79. ERYtech Pharma Company Detail
Table 80. ERYtech Pharma Business Overview
Table 81. ERYtech Pharma Leukemia Therapeutics Product
Table 82. ERYtech Pharma Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 83. ERYtech Pharma Recent Development
Table 84. Celgene Company Detail
Table 85. Celgene Business Overview
Table 86. Celgene Leukemia Therapeutics Product
Table 87. Celgene Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Celgene Recent Development
Table 89. Genmab Company Detail
Table 90. Genmab Business Overview
Table 91. Genmab Leukemia Therapeutics Product
Table 92. Genmab Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Genmab Recent Development
Table 94. Cephalon Company Detail
Table 95. Cephalon Business Overview
Table 96. Cephalon Leukemia Therapeutics Product
Table 97. Cephalon Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Cephalon Recent Development
Table 99. Clavis Pharma Company Detail
Table 100. Clavis Pharma Business Overview
Table 101. Clavis Pharma Leukemia Therapeutics Product
Table 102. Clavis Pharma Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 103. Clavis Pharma Recent Development
Table 104. Pfizer Company Detail
Table 105. Pfizer Business Overview
Table 106. Pfizer Leukemia Therapeutics Product
Table 107. Pfizer Revenue in Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Leukemia Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Gleevec Features
Figure 4. Sprycel Features
Figure 5. Tasigna Features
Figure 6. Clolar Features
Figure 7. Others Features
Figure 8. Global Leukemia Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Leukemia Therapeutics Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Leukemia Therapeutics Report Years Considered
Figure 13. Global Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Leukemia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Leukemia Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Leukemia Therapeutics Market Share by Players in 2022
Figure 17. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Leukemia Therapeutics Revenue in 2022
Figure 19. North America Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Leukemia Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Leukemia Therapeutics Market Share by Country (2018-2033)
Figure 25. Germany Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Leukemia Therapeutics Market Share by Region (2018-2033)
Figure 33. China Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Leukemia Therapeutics Market Share by Country (2018-2033)
Figure 41. Mexico Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Leukemia Therapeutics Market Share by Country (2018-2033)
Figure 45. Turkey Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Leukemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 51. Eisai Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 52. Biogen Idec Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 53. ERYtech Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 54. Celgene Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 55. Genmab Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 56. Cephalon Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 57. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Leukemia Therapeutics Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed